fbpx Skip to main content

Member's Profile

Vertex Pharmaceuticals

3215 Merryfield Row
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 1999
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Vertex Pharmaceuticals
Biotech Company
Vertex Pharmaceuticals Incorporated is a global biotechnology company. Vertex seeks to discover, develop, and commercialize major pharmaceutical products independently and with partners. Chemogenomics, Vertex’s proprietary, systematic, genomics-based platform, is designed to accelerate the discovery of new drugs and to expand intellectual property coverage of drug candidate compounds and classes of related compounds. This approach, which targets gene families, has formed the basis for several commercial collaborations under which Vertex retains rights to downstream revenue. Vertex’s first approved product is Agenerase (amprenavir), an HIV protease inhibitor, which Vertex co-promotes with GlaxoSmithKline. Vertex has more than 12 drug candidates in clinical and preclinical development to treat viral diseases, inflammation, cancer, autoimmune diseases, neurological disorders and genetic disorders.
Related News
Biocom Institute’s Veterans in Life Science Symposium a Success
May 16, 2019
... Read more.